Pancreatic Cancer Research

ResearcherUniversität UlmActive in the last 2 years

Karolin Walter

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6163-7182; OpenAlex author ID A5063946757. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: 3 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 9

  1. A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-026-48584-2↗
  2. Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. Co-author DOI 10.1136/gutjnl-2019-319970↗
  3. RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-2633↗
  4. Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells. Co-author DOI 10.3390/cancers13133145↗
  5. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Co-author DOI 10.1038/s41467-020-18954-z↗
  6. A feedback-loop between telomerase activity and stemness factors regulates PDAC stem cells Co-author DOI 10.1101/2020.11.02.361931↗
  7. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. First author DOI 10.1177/2050640620905183↗
  8. MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo. Co-author DOI 10.1155/2019/8475389↗
  9. Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. First author DOI 10.1016/j.scr.2016.08.007↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Theodor Werner Seufferlein · 8 shared papers, 2016–2026 · strength 0.80
  2. Patrick Christian Hermann · 8 shared papers, 2016–2026 · strength 0.79
  3. Bruno Sáinz · 7 shared papers, 2019–2026 · strength 0.74
  4. Alexander Kleger · 7 shared papers, 2016–2026 · strength 0.72
  5. Frank Arnold · 6 shared papers, 2020–2026 · strength 0.68
  6. Kanishka Tiwary · 5 shared papers, 2019–2026 · strength 0.57
  7. Pierre‐Olivier Frappart · 5 shared papers, 2020–2021 · strength 0.44
  8. Johann Gout · 4 shared papers, 2019–2021 · strength 0.35
  9. Eva Rodríguez-Aznar · 4 shared papers, 2019–2021 · strength 0.35
  10. Elisabeth Heßmann · 2 shared papers, 2021–2026 · strength 0.32
  11. Sonia Alcalá · 2 shared papers, 2020–2026 · strength 0.32
  12. Lukas Perkhofer · 4 shared papers, 2016–2021 · strength 0.31
  13. Anton Lahusen · 1 shared paper, 2026 · strength 0.23
  14. Martin Müller · 3 shared papers, 2016–2021 · strength 0.22
  15. Hans Armin Kestler · 2 shared papers, 2021 · strength 0.19
  16. Élodie Roger · 2 shared papers, 2021 · strength 0.19
  17. Thomas Jens Ettrich · 2 shared papers, 2020–2021 · strength 0.18
  18. Mert Erkan · 2 shared papers, 2020–2021 · strength 0.18
  19. Steven A. Johnsen · 1 shared paper, 2021 · strength 0.09
  20. Zeynab Najafova · 1 shared paper, 2021 · strength 0.09
  21. Sebastian Lange · 1 shared paper, 2021 · strength 0.09
  22. Stephan A. Hahn · 1 shared paper, 2021 · strength 0.09
  23. Roland Rad · 1 shared paper, 2021 · strength 0.09
  24. Diane M. Simeone · 1 shared paper, 2021 · strength 0.09
  25. Marta Alonso‐Nocelo · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.